Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
American Society for Cell Biology Annual Meeting
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.
Biogen Idec completes purchase of full rights and control of Tysabri®
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
A full genome search in multiple sclerosis.
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Alemtuzumab for the Treatment of Multiple Sclerosis
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis.
Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.

Pages